Fresenius SE & Co. KGaA logo

Fresenius SE & Co. KGaA

TickerFRE.DEVenueXETRASectorHealthcarePrimary listingBeta0.83
€44.91-0.38%
FinScore54

Fresenius SE & Co. KGaA is a Germany-based company in the Healthcare sector with a market capitalisation of $28.4B. Its FinScore is 54/100; its highest-scoring layer is Momentum (75) and its lowest is Growth (23). The shares trade at 15.5x trailing earnings and are down 6% year to date.

Market cap
$28.4B
P/E (TTM)
15.5x
Dividend yield (TTM)
2.33%
ROE
8.3%

Share price performance

Loading chart…

About Fresenius SE & Co. KGaA

www.fresenius.com

Fresenius SE & Co. KGaA operates as a diverse healthcare enterprise, supplying a comprehensive array of products and services primarily focused on dialysis, hospital management, and outpatient medical care. Its activities are structured across four main divisions: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care division is dedicated to individuals living with chronic kidney failure, offering essential items like dialyzers, hemodialysis machines, and related disposable supplies, alongside various dialysis-specific services. Fresenius Kabi concentrates on the therapeutic treatment and care of ill patients. Its extensive product range includes intravenous pharmaceuticals, such as generic drugs for oncology, anesthetics, pain relief, anti-infectives, and critical care. Additionally, it provides parenteral and enteral nutritional products, infusion solutions, and blood volume expanders for infusion therapy. The segment also develops biosimilars—biological medicines for autoimmune and cancer conditions—and manufactures medical devices and disposables crucial for administering IV generics, infusion treatments, and clinical nutrition. Transfusion products for blood component collection and corporeal therapies are also part of its offerings. Fresenius Helios manages significant healthcare operations, encompassing 90 hospitals, approximately 130 outpatient clinics, and 6 prevention centers throughout Germany. In Spain, its presence includes 49 hospitals, 88 outpatient clinics, and around 300 risk prevention centers. This segment also delivers fertility treatment services through 33 clinics and an additional 39 sites located across 10 countries on three continents. Finally, the Fresenius Vamed division specializes in project management and service delivery for hospitals and other healthcare facilities. Its offerings span project development, meticulous planning, and turnkey construction solutions. Furthermore, it provides ongoing maintenance, technical oversight, and operational management services. The company, initially known as Fresenius SE, officially changed its name to Fresenius SE & Co. KGaA in January 2011. Founded in 1912, Fresenius SE & Co. KGaA maintains its corporate headquarters in Bad Homburg vor der Höhe, Germany.

Profile
Sector
Healthcare
Industry
Medical - Care Facilities
HQ
Germany
Fiscal year-end
December
Trading currency
EUR
Reporting currency
EUR
Fundamentals updated
71 days ago
Market
Market cap
$28.4B
Shares outstanding
563.2M
P/E (TTM)
15.5x
Dividend yield (TTM)
2.33%
Beta (issuer)
0.82
Revenue (latest FY)
€22.9B

Revenue breakdown

Revenue split not available

FinScore

As of 2026-10-19
Overall54
Quality68
Growth23
Value61
Momentum75
Relative Strength44

Snapshot

Ownership

Free float
72.9%
Shares outstanding
563.2M

Holder data is not available for this company yet.

Sign up or log in to see Analysis

Analysis for Fresenius SE & Co. KGaA is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Financials

Financials for Fresenius SE & Co. KGaA is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Estimates

Estimates for Fresenius SE & Co. KGaA is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Peers

Peers for Fresenius SE & Co. KGaA is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see Valuation

Valuation for Fresenius SE & Co. KGaA is available to Finryse members. The Overview stays open to everyone; creating an account is free.

Sign up or log in to see News

News for Fresenius SE & Co. KGaA is available to Finryse members. The Overview stays open to everyone; creating an account is free.